Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases

Central Nervous System

Notorious Hyperkalemia: What are the causes, si...

Bananas! Mostly everyone loves bananas. Who wouldn’t? They taste good and they are a rich source of potassium. Besides lovely bananas, oranges, cantaloupe, honeydew, apricots, grapefruit, red meat ...

Jan 29, 2021

eating-disorders-sign-symptoms-risk-factor-types-diagnosis-and-treatment-options
Eating Disorders: What Happens When Stigma And Misconceptions Command The Health

As per the National Association of Anorexia Nervosa and Associated Disorders, (ANAD), worldwide, at least 9% of the population is affected by eating disorders. Eating disorders is a psychological condition that disturbs eating habits. Eating disorders affect thoughts and emotions, and the people with the disease be...

Find More
mental-health-diseases-disorders-challanges-issues-causes-types-risk-factors-sign-symptoms-treatment
The Burden And The Impact Of Mental Health Issues In Today’s Time

Mental health today is a global burden causing a significant number of deaths. It is rapidly increasing and contributing to ill health in both developed and developing countries.  According to Jürgen Rehm et al., “mental and addictive disorders affected more than 1 billion people globally in 2016. They caused ...

Find More
Biohaven's Troriluzole; Daiichi/ AZ's Enhertu; Fujifilm Manufacturing Units
Biohaven’s Troriluzole Failure; Daiichi/ AZ’s Enhertu; Fujifilm & Manufacturing Spree; J&J’s Darzalex Faspro

Biohaven's Troriluzole Dwindles Again In Alzheimer’s After Anxiety  Biohaven Pharmaceuticals had put too much faith in its third-generation prodrug, Troriluzole. The company has tested the efficacy of the drug in more than one indication, including generalized anxiety disorder (GAD), obsessive-compulsive di...

Find More

More Views & Analysis

Parkinson’s Disease Cure and Treatment
Parkinson’s Disease: How close are we to a cure?

Neurological disorders are the leading source of disability globally, and Parkinson's is the fastest-growing neurological condition. It could be due to several factors ranging from an increase in geriatric population, longevity, improved diagnostics methodologies, a better understanding of the disease to the specif...

Find More

Pfizer’s Somatrogon; SCONE device; ATG-010; SanBio in Neurology
Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results

Pfizer and OPKO Health: A step closer to FDA Nod for pediatric growth hormone deficiency (GHD) drug, Somatrogon Pfizer and Opko had joined hands in 2014 to develop somatrogon, a pediatric growth hormone deficiency (GHD) drug. It comprises the natural sequence of growth hormone and a copy of the C-terminal peptid...

Find More

Bipolar Depression Market |Bipolar Depression Pipeline
Watch Out For Top Pipeline Therapies Making An Impact In The Bipolar Depression Market

Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar disorder. Since most patients exhibit depression, Bipolar depression gets misdiagnosed with other mental disorders easily. Thus, it is associated...

Find More

Frequently Asked Questions About Epilepsy And Seizures
21 of the most common questions about Epilepsy

The term Epilepsy isn’t new. It’s been present in the air for centuries now, however, only a few are aware that it is one of the most common neurological diseases in the world. It affects around 50 million people worldwide. However, public awareness regarding Epilepsy is quite less and it can result in the ris...

Find More

Atsena raises $55M; Neuron23’s strategy for CNS disorders; and more
Mitochondria destruction for Cancer Treatment; Atsena raises USD 55 Million financings; Novartis and Cadent Therapeutics collaboration; Neuron23’s strategy to tackle CNS disorders

Mitochondria destruction can help in Cancer Treatment  Human cells require structures known as mitochondria for the generation of energy for their biochemical activities. Researchers at the Karolinska Institutet in Sweden thought that destroying these could be a strategy for cancer treatment.  Follo...

Find More

Retinal Vein Occlusion Market | Retinal Vein Occlusion Market Emerging Therapies | Retinal Vein Occlusion Market Pharma companies
Top Emerging Therapies To Watch Out for in the Retinal Vein Occlusion Market

Recent years started witnessing the emergence of novel treatment approaches that have been keeping the Retinal vein occlusion market in a hyped-up state. Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. T...

Find More

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Thera.....

Find More

Neuroendocrine tumors (NET) are a rare kind neoplasm that arises from cells of the endocrine (hormon.....

Find More

The medical device (MedTech) industry has small and big companies operating in various segments such.....

Find More

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Find More

Alzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroy.....

Find More

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that results in systemic inflamma.....

Find More